Sep 6, 2021
Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care
25 minutes
Podcast · Inglés
PeerVoice Endocrinology & Metabolic Disorders Audio
PeerVoice, 1140 Avenue of the Americas, 15th Floor, New York, NY 10036
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Episodes
Ordered by publication date.
Aug 31, 2021
Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!
17 minutes
Aug 10, 2021
Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes
31 minutes
Aug 6, 2021
Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes
44 minutes
Jul 16, 2021
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
8 minutes
Jun 23, 2021
Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
8 minutes
Jun 17, 2021
Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs
21 minutes
Jun 10, 2021
Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin
32 minutes
May 3, 2021
"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"
39 minutes
Apr 30, 2021
Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?
19 minutes
Feb 3, 2021
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
44 minutes
Jan 20, 2021
Modern Management of Chronic Kidney Disease: A Look to the Future
10 minutes
Jan 8, 2021
SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020
37 minutes
Jan 6, 2021
Novel Strategies for Chronic Kidney Disease: New Data, New Paradigm?
21 minutes
Jan 6, 2021
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights of Kidney Week 2020
10 minutes
More related podcasts
Other podcasts in Science & Medicine.